PATTIES FOODS Asset Resilience Ratio
PATTIES FOODS asset resilience ratio. PATTIES FOODS (PH4) has an Asset Resilience Ratio of 12.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PATTIES FOODS (PH4) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of PATTIES FOODS (2020–2025)
Asset resilience ratio of PATTIES FOODS from 2020 to 2025. This chart shows how PATTIES FOODS's Asset Resilience Ratio has changed over time. Read PATTIES FOODS (PH4) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down PATTIES FOODS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PATTIES FOODS (PH4) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €165.00 Million | 12.15% |
| Total Liquid Assets | €165.00 Million | 12.15% |
Asset Resilience Insights
- Moderate Liquidity: PATTIES FOODS has 12.15% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
PATTIES FOODS Industry Peers by Asset Resilience Ratio
Compare PATTIES FOODS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai Medicilon Inc
SHG:688202 |
Biotechnology | 6.69% |
|
Blue Jet Healthcare Limited
NSE:BLUEJET |
Biotechnology | 13.81% |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
Biotechnology | 0.56% |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
Biotechnology | 79.76% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
PATTIES FOODS Asset Resilience Ratio by Year (2020–2025)
PATTIES FOODS asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for PATTIES FOODS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 12.15% | €165.00 Million ≈ $192.90 Million |
€1.36 Billion ≈ $1.59 Billion |
-8.31pp |
| 2024-12-31 | 20.45% | €285.00 Million ≈ $333.19 Million |
€1.39 Billion ≈ $1.63 Billion |
+18.65pp |
| 2023-12-31 | 1.81% | €30.00 Million ≈ $35.07 Million |
€1.66 Billion ≈ $1.94 Billion |
-27.70pp |
| 2022-12-31 | 29.50% | €483.41 Million ≈ $565.15 Million |
€1.64 Billion ≈ $1.92 Billion |
-13.80pp |
| 2021-12-31 | 43.30% | €983.62 Million ≈ $1.15 Billion |
€2.27 Billion ≈ $2.66 Billion |
+33.50pp |
| 2020-12-31 | 9.81% | €369.00 Million ≈ $431.39 Million |
€3.76 Billion ≈ $4.40 Billion |
-- |
About PATTIES FOODS
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more